First Interstate Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,128
| Closed | -$305K | – | 171 |
|
|
2022
Q1 | $305K | Buy |
+5,128
| New | +$328K | 0.03% | 99 |
|
|
2020
Q3 | – | Sell |
-7,010
| Closed | -$539K | – | 130 |
|
|
2020
Q2 | $539K | Sell |
7,010
-73,347
| -91% | -$5.62M | 0.07% | 102 |
|
|
2020
Q1 | $6.01M | Sell |
80,357
-5,641
| -7% | -$390K | 1.5% | 14 |
|
|
2019
Q4 | $5.59M | Sell |
85,998
-7,926
| -8% | -$516K | 1.25% | 26 |
|
|
2019
Q3 | $5.95M | Sell |
93,924
-3,194
| -3% | -$209K | 1.38% | 24 |
|
|
2019
Q2 | $6.56M | Sell |
97,118
-3,616
| -4% | -$238K | 1.45% | 21 |
|
|
2019
Q1 | $6.55M | Sell |
100,734
-2,598
| -3% | -$173K | 1.46% | 22 |
|
|
2018
Q4 | $6.46M | Sell |
103,332
-3,040
| -3% | -$212K | 1.6% | 18 |
|
|
2018
Q3 | $8.21M | Sell |
106,372
-2,886
| -3% | -$218K | 1.73% | 14 |
|
|
2018
Q2 | $7.74M | Sell |
109,258
-5,864
| -5% | -$414K | 1.71% | 15 |
|
|
2018
Q1 | $8.68M | Sell |
115,122
-4,346
| -4% | -$345K | 1.96% | 11 |
|
|
2017
Q4 | $8.56M | Buy |
119,468
+2,367
| +2% | +$180K | 1.82% | 19 |
|
|
2017
Q3 | $9.49M | Buy |
117,101
+5,128
| +5% | +$392K | 2.04% | 14 |
|
|
2017
Q2 | $7.92M | Sell |
111,973
-2,806
| -2% | -$187K | 1.64% | 17 |
|
|
2017
Q1 | $7.8M | Sell |
114,779
-2,679
| -2% | -$188K | 1.61% | 19 |
|
|
2016
Q4 | $8.41M | Buy |
117,458
+12,373
| +12% | +$920K | 1.66% | 21 |
|
|
2016
Q3 | $8.31M | Buy |
105,085
+916
| +0.9% | +$74.4K | 1.7% | 19 |
|
|
2016
Q2 | $8.69M | Buy |
104,169
+2,814
| +3% | +$250K | 1.81% | 16 |
|
|
2016
Q1 | $9.31M | Buy |
101,355
+1,662
| +2% | +$150K | 1.95% | 14 |
|
|
2015
Q4 | $10.1M | Buy |
99,693
+829
| +0.8% | +$86.3K | 2.09% | 13 |
|
|
2015
Q3 | $9.71M | Buy |
98,864
+5,974
| +6% | +$663K | 2.07% | 13 |
|
|
2015
Q2 | $10.9M | Sell |
92,890
-1,966
| -2% | -$215K | 1.66% | 16 |
|
|
2015
Q1 | $9.31M | Sell |
94,856
-1,825
| -2% | -$185K | 1.44% | 20 |
|
|
2014
Q4 | $9.11M | Buy |
96,681
+408
| +0.4% | +$42.2K | 1.5% | 22 |
|
|
2014
Q3 | $10.2M | Sell |
96,273
-5,606
| -6% | -$549K | 2.2% | 11 |
|
|
2014
Q2 | $8.45M | Buy |
101,879
+22,182
| +28% | +$1.73M | 1.74% | 19 |
|
|
2014
Q1 | $5.65M | Sell |
79,697
-1,277
| -2% | -$100K | 1.24% | 37 |
|
|
2013
Q4 | $6.08M | Sell |
80,974
-2,760
| -3% | -$192K | 1.48% | 33 |
|
|
2013
Q3 | $5.26M | Buy |
83,734
+1,314
| +2% | +$78.5K | 1.42% | 39 |
|
|
2013
Q2 | $4.23M | Buy |
+82,420
| New | +$4.3M | 1.32% | 44 |
|
Other funds holding GILD
First Interstate Bank's GILD Position: Q2 2022 in Review
First Interstate Bank sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 5,128 shares — an estimated $305K sold.
First Interstate Bank first reported a position in GILD in Q2 2013 and held it in 30 quarters. The position peaked at $10.9M in Q2 2015. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- First Interstate Bank reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
- First Interstate Bank sold 5,128 Gilead Sciences shares in Q2 2022, an estimated $305K.
- First Interstate Bank first reported a position in Gilead Sciences in Q2 2013 and held it in 30 quarters.
- First Interstate Bank's Gilead Sciences position peaked at $10.9M in Q2 2015.
- 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on First Interstate Bank's 13F filing for Q2 2022, filed 12 Aug 2022.